Strategic Advisory Group of Experts on Immunization

Strategic Advisory Group of Experts on Immunization
Name	Strategic Advisory Group of Experts on Immunization
Abbreviation	SAGE
Formation	1999
Founder	World Health Organization
Type	Advisory committee
Headquarters	Geneva
Region served	Global
Parent organization	World Health Organization

Strategic Advisory Group of Experts on Immunization

The Strategic Advisory Group of Experts on Immunization is the principal advisory group to the World Health Organization on vaccines and immunization. It provides guidance for global World Health Organization policy, interacts with technical bodies such as the Global Vaccine Action Plan, and influences initiatives including the Expanded Programme on Immunization, Gavi, the Vaccine Alliance, and national immunization programs. SAGE deliberations connect academic institutions, regulatory agencies, and international initiatives to inform vaccine policy and public health practice.

History and Establishment

SAGE was established by the World Health Organization in 1999 following reviews of the Expanded Programme on Immunization and consultations with stakeholders including the United Nations Children's Fund, the World Bank, and the Bill & Melinda Gates Foundation. Its creation responded to policy challenges highlighted by events such as the resurgence of measles in the 1990s and the introduction of new vaccines after breakthroughs by researchers at institutions like the Centers for Disease Control and Prevention and the London School of Hygiene & Tropical Medicine. Early meetings incorporated expertise drawn from advisory models used by bodies such as the Advisory Committee on Immunization Practices and the European Medicines Agency scientific committees.

Organization and Membership

SAGE is composed of independent experts nominated through WHO procedures and appointed by the Director-General of the World Health Organization. Membership includes clinicians, epidemiologists, immunologists, vaccinologists, public health practitioners and ethicists from institutions such as the Johns Hopkins Bloomberg School of Public Health, the National Institutes of Health, and the Karolinska Institutet. Observers have included representatives from United Nations Children's Fund, Gavi, the Vaccine Alliance, the World Bank, and regulatory authorities like the European Medicines Agency and the U.S. Food and Drug Administration. SAGE establishes working groups and ad hoc technical advisory panels drawing specialists from universities, national public health agencies, and partners such as the Bill & Melinda Gates Foundation and the Wellcome Trust.

Mandate and Functions

SAGE’s mandate, as directed by the World Health Organization Executive Board, is to advise on vaccine use, immunization strategies, and prioritization of vaccine-product introduction for diseases including measles, polio, influenza, and more recently, SARS-CoV-2. Functions include developing strategic recommendations for the Global Vaccine Action Plan, informing vaccine schedules compatible with the Expanded Programme on Immunization, and advising on vaccine safety signal assessment in collaboration with agencies such as the U.S. Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control. SAGE also guides evidence translation for policymakers in countries and multilateral funders like Gavi, the Vaccine Alliance and the World Bank.

Decision-Making and Evidence Evaluation

SAGE relies on systematic reviews, modelling studies, randomized controlled trials, observational studies, and vaccine regulatory assessments from agencies like the European Medicines Agency and the U.S. Food and Drug Administration. It commissions working groups to synthesize data from institutions including the London School of Hygiene & Tropical Medicine, the Institut Pasteur, and the National Institutes of Health. The group employs frameworks for benefit–risk assessment and considers ethical guidance influenced by bodies such as the Nuffield Council on Bioethics and the Council for International Organizations of Medical Sciences. Decisions are reached by consensus among members, informed by inputs from partners like UNICEF, Gavi, the Vaccine Alliance, and national immunization technical advisory groups modeled on SAGE.

Major Recommendations and Impact

SAGE recommendations have shaped global policy on rotavirus vaccine introduction, pneumococcal conjugate vaccine schedules, human papillomavirus immunization strategies, and use of fractional-dose inactivated poliovirus vaccine. Their guidance influenced rollouts of vaccines from manufacturers and developers including GlaxoSmithKline, Pfizer, and Moderna during the COVID-19 pandemic, and shaped allocation frameworks coordinated with the Access to COVID-19 Tools Accelerator and COVAX. Past recommendations have accelerated elimination strategies for diseases guided by initiatives such as the Polio Eradication Initiative and informed updates to the International Health Regulations (2005)-relevant response planning.

Challenges and Criticisms

SAGE has faced critiques about transparency, potential conflicts of interest due to links between experts and vaccine manufacturers like GlaxoSmithKline or funders such as the Bill & Melinda Gates Foundation, and the timeliness of recommendations during emergencies such as the 2014–2016 West African Ebola epidemic and the COVID-19 pandemic. Questions have been raised regarding equity in access when recommendations intersect with procurement mechanisms led by Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Calls for broader regional representation and engagement with national advisory groups, including National Immunization Technical Advisory Groups modeled after SAGE, have been recurrent themes in evaluations by the World Health Assembly and independent review panels.

Relationship with WHO and Global Immunization Policy

SAGE functions as an expert advisory body to the World Health Organization Director-General and informs deliberations at the World Health Assembly and the WHO Executive Board. Its guidance is a key input to global strategies like the Global Vaccine Action Plan and operational programs including the Expanded Programme on Immunization. Coordination with partners such as UNICEF, Gavi, the Vaccine Alliance, the World Bank, and regulatory agencies ensures that SAGE recommendations translate into procurement, financing, and implementation decisions across countries and multilateral initiatives such as COVAX and the Access to COVID-19 Tools Accelerator.

Category:World Health Organization Category:Vaccination